50th Anniversary Logo

The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

May 7, 2024

APC PUBLISHES DOCUMENTS ON COMPOUNDED KETAMINE, CLINIC DIRECT BILLING, CONSTRUCTIVE TRANSFER, PEPTIDE COMPOUNDING

The Alliance for Pharmacy Compounding (APC) has published two documents aimed at helping pharmacy compounders use best practices for preparing and dispensing compounded ketamine by pharmacies and for clinic direct billing for patient-specific compounded medications by compounding pharmacies. Developed by a working group of APC member experts, the documents represent an effort to establish a baseline for care and compliance by compounding pharmacies. APC has also updated its briefing paper on constructive transfer and released a statement on peptide compounding, which equip compounders to comply fully with current law and regulation. 

[Best Practices for Preparing and Dispensing Compounded Ketamine by Pharmacies; Recommended Best Practices for Clinic Direct Billing (Office Pay) for Patient-Specific Compounded Medications by Compounding Pharmacies; BRIEFING: Constructive Transfer and Compounding Controlled Substance Medications; Statement Of The Alliance For Pharmacy Compounding: Understanding Law And Regulation Governing The Compounding Of Peptide Products. Alliance for Pharmacy Compounding. March and April 2024.]